Prof. Xuezhen Yang, M.D., Ph.D. is a distinguished urologist and academic leader in China. He currently serves as Professor and Chairman of the Department of Urology and Distinguished Professor at the Laboratory Center, Lvliang Hospital of Shanxi Medical University.

His expertise spans urological oncology, renal and prostate disorders, minimally invasive surgery, and translational laboratory research. Prof. Yang has contributed significantly to advancing clinical practice in urology, combining patient care with scientific investigation to improve therapeutic outcomes.

Based in Lvliang, Shanxi Province, he is recognized for his leadership in medical education, clinical innovation, and research excellence.

• Urological Oncology
• Renal & Prostate Disorders
• Minimally Invasive Surgery
• Clinical Pharmacology in Urology
• Laboratory & Translational Medicine

• Lv Y., Shi D., Wang H., Liu R., Yang X.. Inflammatory and immunomodulatory regulatory mechanisms in benign prostatic hyperplasia. Journal of Men’s Health;(Accepted; Corresponding Author)
• Yang X., Liu Z., Liu J., Yang P., Sun Z., Liu B., Guo J.. The effect of cytokines on neuroendocrine differentiation in prostate cancer. J Mens Health. 2025;21(12):22-26;(First Author & Corresponding Author)
• Yang X., Fu J., Ma M.. Effect of COVID-19 on Male Reproduction. J Mens Health. 2024;20(7):15-19;(First Author & Corresponding Author)
• Project team of Chinese medicine diagnosis and treatment guide for female stress urinary incontinence of China Association of Chinese Medicine. Chinese medicine diagnosis and treatment guide for female stress urinary incontinence(2023). Journal of Traditional Chinese Medicine. 2024;65(13):1408-1416；（Project team member）
• Dong Z., Guan C., Yang X.. Prediction of Fuhrman pathological grade of renal clear cell carcinoma based on CT texture analysis. Am J Clin Exp Urol. 2024;12(1):28-35;(Corresponding Author)
• Fu J., Luo W., Ding Y., Liu X., Fang W., Yang X.. Clinical study of 3D laparoscopic radical prostatectomy by transperitoneal and extraperitoneal approaches. Am J Clin Exp Urol. 2023;11(6):549-558;(Corresponding Author)
• Yang X., Xu M., Guo C., Fu J.. Research progress on surgical factors related to early urinary control after laparoscopic radical prostatectomy. Am J Clin Exp Urol; 2023;11(5):361-366;(First Author & Corresponding Author)
• Ning J., Cheng T., Ye D., Zha Z., Wu G., Xu H., Yang X., Fang W. Henan J Surg. 2023;29(01):46-49；
• Fu J., Ding Y., Ma X., Wu G., Zha Z., Ning J., Xu W., Guan C., Yang X.. 3D laparoscopic resection of renal venous aneurysms: a rare case report. Am J Clin Exp Urol. 2022;10(5):353-357;(Corresponding Author)
• Li Y., Ma X., Guan C., Yang X.. Analysis of the influence of marital status on prognosis of prostate cancer patients based on big data. Am J Clin Exp Urol. 2022;10(5):320-326;(Corresponding Author)
• Ma X., Li Y., Fu J., Yang X.. Effect of 3D laparoscopic surgery for ureteral stricture. Am J Clin Exp Urol. 2022;10(5):345-352;(Corresponding Author)
• Ye D., Ma X., Yang X.. Scrotal calcinosis: a case report and literature review. Am J Clin Exp Urol. 2022;10(3):194-198;(Corresponding Author)
• Yang X., Fu J., Ma X.. How to improve the laparoscopic technique of urologist. Advances in Laparoscopy. 2022;5(1):127-130;(First Author & Corresponding Author)
• Ma X., Jiang X., Yang X.. Mechanisms of castration resistant prostate cancer formation and progression through neuroendocrine differentiation. J Mens Health. 2021;17(4):17-21;(Corresponding Author)
• Jiang X., Cao H., Ma X., Yang X.. Value of the prediction of infectious kindey stones based on CT radiomics model. Anhui Medical and Pharmaceutical Journal. 2021;25(07):1401-1406;(Corresponding Author)
• Yang, X., Jiang X., Ma X., Habuchi T., Guo Y.. A Novel Research Area of PCDH-PC in Inhibition of Prostate Cancer Cells Invasion and Metastasis through Epithelial-Mesenchymal Transition. Immunotherapy: Open Access. 2020;6(3):1-4;(First Author & Corresponding Author)
• Yang, X., Shan L., Cao H., Jiang X., Ma X.. A valuable MRI examination method for prostate cancer screening. Medicine. 2020;99(48):e23134;(First Author & Corresponding Author)
• Chen, J., Liu, X., Ke, K., Zou, J., Gao, Z., Habuchi, T, Yang, X.. LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression. BMC Cancer. 2020;20(1):749;(Corresponding Author)
• Liu, S., Qi Y., Zhou, Z., Yang, X.. Diffusion-weighted imaging eADC value in differential diagnosis of benign and malignant prostatic nodules. Chin Med Herald. 2020;17(4):159-162;(Corresponding Author)
• Jiang X., Cao H., Wu G., Dong Z., Yang, X.. A case of retroperitoneal neurilemmoma and literature review. Chin Med Herald. 2020;17(3):159-180;(Corresponding Author)
• Yang, X., Jiang, X., Habuchi, T., Guo, Y. The effect of Protocadherin-PC with Epithelial Mesenchymal Transition in prostate cancer cells. Chin J Gen Pract. 2019;17(11):1833-1836; (First Author & Corresponding Author)
• Hu, M., Guan. C., Xu, H., Gu, M., Fang, W., Yang, X.. Comparison of 3-dimensional laparoscopy and conventional laparoscopy in the treatment of complex renal tumor with partial nephrectomy: A propensity score-matching analysis. Medicine. 2019;98(40):e17435;
• Shan, L., Qu, S., Jiang, X., Yang, X.. Value of MRI DWI combined with PI-RADS in screening prostate cancer. Chin Med Herald. 2019;16(25):142-145;(Corresponding Author)
• Shan, L., Qu, S., Shi, S., Jiang, X., Yang, X.. Value of MRI apparent diffusion coefficient for screening prostate cancer. J Mol Imaging. 2019;42(2):151-154;(Corresponding Author)
• Yang, X., Jiang, X., Wang, H., Zhu, H. Experiences exploration of seminal vesicle endoscopy technology in diagnosis and treatment of refractory hemospermia. J Mol Imaging. 2019;42(1):43-45;(First Author & Corresponding Author)
• Yang, X., Wang, H., Zhu, H.. Analysis of the “PCE” three joint approach for teaching effectiveness in urology. Clin Med Education. 2016;20(10):66;(First Author & Corresponding Author)
• Terry S., Yang X., Chen, M.-W., Vacherot F., Buttyan R. Multifaceted Interaction between the Androgen and Wnt Signaling Pathways and the Implication for Prostate Cancer. J Cell Biochem. 2006;99(2):402-410;
• Yang, X., Chen, M.-W., Terry, S., Vacherot, F., Bemis, D. L., Capodice, J., Guo, Y. and Buttyan, R.. Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells. Oncogene. 2006;25(24):3436–3444;
• Vacherot, F., Terry, S., Faucon, H., Queires, L., Chen, M.-W., Yang, X., Gil Diez de Medina, S., Verdier, A., Azoulay, S., Allory, Y., Abbou, CC., Buttyan R., de la Taille, A.. Protocadherin-PC discovery and its implication in prostate cancer progression. Prog Urol. 2005;15(6 Suppl 1):1294-1302;
• Yang, X., Chen, M.-W., Terry, S., Vacherot, F., Chopin, D. K., Bemis, D. L., Kitajewski, J., Benson, M. C., Guo, Y. and Buttyan, R.. A human-and male-specific protocadherin that acts through the Wnt signaling pathway to induce neuroendocrine transdifferentiation. Cancer Res. 2005;65(12):5263-5271;
• Wang, J., Zhou, L., Yang, X., Ai, J., Xin, D., Na, Y., Guo, Y.. Up-regulated expression of a prostate cancer-related gene, NSBP1, in prostate cancer cells. Basic Med Sci and Clin. 2004;24(4):393-397;
• Jin, J., Ren, L., Yang, X., Guo, Y.. Screening for microdeletions of AZF region of Y chromosome in patients with spermatogenetic malfunction and its significance. Chin J Surg. 2004;25(3):203-206;
• Jin, J., Ren, L., He, L., Yang, X., Na, Y., Guo, Y.. Construction and Identification of directional expressing cDNA library from normal testis in Chinese males. Chin J Urol. 2004;25(1):41-43;
• Song, W., Zhou, L., Liang, L., Yang, X., Ai, J., Na, Y., Zhang, Z., Guo, Y.. Expression of dihydrodiol dehydrogenase 2 in prostate cancer and its significance. Chin J Urol. 2003;24(9):625-627;
• Yang, X., Zhou, L., Zhou, J., Wang, X., Yang, F., Zhang, Z., Na, Y., Gu, F., Guo, Y.. Cloning of the prostate cancer related genes with mRNA differential display. Chin J Urol. 2003;24(8):545-547;
• Zhou, L., Yang, X., Zeng, L., Liang, L., Yang, X., Ren, L., Li, C., Zhang, Z., Na, Y., Gu, F., Guo, Y.. Expression and significance of Clusterin in normal prostate, benign prostate hyperplasia(BPH) and prostate neoplasm. Chin J Surg. 2003;41(2):93-95;
• Zhou, L., Yang, X., Liang, L., Zhang, Q., Li, C., Zhang, Z., Na, Y., Guo, Y.. Expression and significance of Clusterin in prostate neoplasm. Chin J Urol. 2002;23(3):181-183;
• Zhou, L., Yang, X., Huang, X., Zhang, Z., Na, Y., Gu, F., Guo, Y.. The elementary research on differentially expressed genes in prostate cancer by cDNA microarray. Chin J Urol. 2002;23(2):72-75.

• Han, M., … Yang, X.. Summary of management of common diseases in urology(1st Edition). Vice Chief Editor. Scientific and Technological Literature Press. Mar, 2019, 1st Impression;
• Yang, X., Hu, Y.. Diagnosis and Surgical Techniques of Urological Diseases(1st Edition). Chief Editor. Scientific and Technological Literature Press. Jun, 2017, 1st Impression;
• Wang, W., … Yang, X., … Zhang, X.. Handbook of Dialysis(4th Edition, edited by John T. Daugirdas, Peter G. Blake, Todd S. Ing). Translation Participant. The People's Medical Publishing House. Jan, 2009, 1st Impression;
• Ding, Y., ... Yang, X., … Xin, Z., Guo, Y.. Andrology, Male Reproductive Health and Dysfunction(2nd Edition, edited by E. Nieschlag, H.M. Behre, H. Van Ahlen, Susan Nieschlage). Translation Participant. Beijing Medical University Press. Sep, 2002, 1st Impression.

No content available to display!!!